Filing Details

Accession Number:
0001209191-21-067647
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-02 17:08:05
Reporting Period:
2021-11-30
Accepted Time:
2021-12-02 17:08:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566044 Vyne Therapeutics Inc. VYNE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055404 G Patrick Lepore 520 U.s. Highway 22, Suite 204
Bridgewater NJ 08807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-30 12,500 $1.02 62,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Shares were purchased pursuant to a 10b5-1 plan entered into by the reporting person on April 21, 2021.
  2. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.98 to $1.03, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.